Streptozocin injected intraperitoneally or intracerebroventricularly has been found to induce the pathologies of sporadic AD, such as insulin deficiency, plaque deposition, tau hyperphosphorylation, and neuronal loss [171,172,173]. Here, MAPT is linked to Alzheimer disease.